11 results
10-K
2020 FY
PRAX
Praxis Precision Medicines Inc
17 Mar 21
Annual report
8:33am
legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review … product access and marketing cost disclosure and transparency measures and, in some cases, designed to encourage importation from other countries
10-Q
2020 Q3
PRAX
Praxis Precision Medicines Inc
23 Nov 20
Quarterly report
4:16pm
. Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing … and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. Legally mandated price controls
424B4
bka6uwyiv4 534qe
16 Oct 20
Prospectus supplement with pricing info
4:02pm
S-1/A
4dam9glz0 9570w0
9 Oct 20
IPO registration (amended)
6:09am
S-1
35lxvl
25 Sep 20
IPO registration
5:19pm
DRS/A
7yt4t7biish2hqy
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
x35fp2ayf2c6vitg
22 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next